Discovering the mechanism and involvement of the methylation of cyclin-dependent kinase inhibitor 2A (CDKN2A) gene and its special locus region in gastric cancer

References

• Torre L, Bray F, Siegel R, et al. Global cancer statistics, 2012.  CA Cancer J Clin. 2015;65(2):87–108.
   PubMed Web of Science ®Google Scholar
• Kakiuchi M, Nishizawa T, Ueda H, et al. Recurrent gain-of-function mutations of RHOA in diffuse-type gastric carcinoma. Nat Genet. 2014;46(6):583–587.
   PubMed Web of Science ®Google Scholar
• Necula L, Matei L, Dragu D, et al. Recent advances in gastric cancer early diagnosis. World J Gastroenterol. 2019;25(17):2029–2044.
   PubMed Web of Science ®Google Scholar
• Wilke H, Muro K, Van Cutsem E, et al. Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial. Lancet Oncol. 2014;15(11):1224–1235.
   PubMed Web of Science ®Google Scholar
• Cats A, Jansen EPM, Van Grieken NCT, et al. Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial. Lancet Oncol. 2018;19(5):616–628.
   PubMed Web of Science ®Google Scholar
• Qu Y, Dang S, Hou P. Gene methylation in gastric cancer. Clin Chim Acta. 2013;424:53–65.
   PubMed Web of Science ®Google Scholar
• Sapari NS, Loh M, Vaithilingam A, et al. Clinical potential of DNA methylation in gastric cancer: a meta-analysis. PLoS One. 2012;7(4):e36275.
   PubMed Web of Science ®Google Scholar
• Liggett WH Jr., Sidransky D. Role of the p16 tumor suppressor gene in cancer. J Clin Oncol. 1998;16(3):1197–1206.
   PubMed Web of Science ®Google Scholar
• Padhi SS, Roy S, Kar M, et al. Role of CDKN2A/p16 expression in the prognostication of oral squamous cell carcinoma. Oral Oncol. 2017;73:27–35.
   PubMed Web of Science ®Google Scholar
• Shima K, Nosho K, Baba Y, et al. Prognostic significance of CDKN2A (p16) promoter methylation and loss of expression in 902 colorectal cancers: cohort study and literature review. Int J Cancer. 2011;128(5):1080–1094.
   PubMed Web of Science ®Google Scholar
• Lima EM, Leal MF, Burbano RR, et al. Methylation status of ANAPC1, CDKN2A and TP53 promoter genes in individuals with gastric cancer. Braz J Med Biol Res. 2008;41(6):539–543.
   PubMed Web of Science ®Google Scholar
• Xu F, C H L, Wong CH, et al. Genome-wide screening and functional analysis identifies tumor suppressor long noncoding RNAs epigenetically silenced in hepatocellular carcinoma. Cancer Res. 2019;79(7):1305–1317.
   PubMed Web of Science ®Google Scholar
• Tahara T, Arisawa T. DNA methylation as a molecular biomarker in gastric cancer. Epigenomics. 2015;7(3):475–486.
   PubMed Web of Science ®Google Scholar
• Fattahi S, Golpour M, Amjadi-Moheb F, et al. DNA methyltransferases and gastric cancer: insight into targeted therapy. Epigenomics. 2018;10(11):1477–1497.
   PubMed Web of Science ®Google Scholar
• Tramontano A, Boffo FL, Russo G, et al. Methylation of the suppressor gene p16INK4a: mechanism and consequences. Biomolecules. 2020;10. DOI:10.3390/biom10030446.
   PubMed Web of Science ®Google Scholar
• Dai CY, Furth EE, Mick R, et al. p16(INK4a) expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation. Gastroenterology. 2000;119(4):929–942.
   PubMed Web of Science ®Google Scholar
• Chen WS, Bindra RS, Mo A, et al. CDKN2A copy number loss is an independent prognostic factor in HPV-negative head and neck squamous cell carcinoma. Front Oncol. 2018;8:95.
   PubMed Web of Science ®Google Scholar
• Nazari Z, Shahryari A, Ghafari S, et al. In utero exposure to gestational diabetes alters DNA methylation and gene expression of CDKN2A/B in langerhans islets of rat offspring. Cell J. 2020;22(2):203–211.
   PubMed Web of Science ®Google Scholar
• Spitzwieser M, Entfellner E, Werner B, et al. Hypermethylation of CDKN2A exon 2 in tumor, tumor-adjacent and tumor-distant tissues from breast cancer patients. BMC Cancer. 2017;17(1):260.
   PubMedGoogle Scholar
• Kempster S, Phillips WA, Baindur-Hudson S, et al. Methylation of exon 2 of p16 is associated with late stage oesophageal cancer. Cancer Lett. 2000;150(1):57–62.
   PubMed Web of Science ®Google Scholar
• Peng D, Zhang H, Sun G. The relationship between P16 gene promoter methylation and gastric cancer: a meta-analysis based on Chinese patients. J Cancer Res Ther. 2014;10(Suppl):292–295.
   PubMedGoogle Scholar
• Pu X, Zhu L, Fu Y, et al. Companied P16 genetic and protein status together providing useful information on the clinical outcome of urinary bladder cancer. Medicine (Baltimore). 2018;97(15):e0353.
   PubMed Web of Science ®Google Scholar
• Liau JY, Liao SL, Hsiao CH, et al. Hypermethylation of the CDKN2A gene promoter is a frequent epigenetic change in periocular sebaceous carcinoma and is associated with younger patient age. Hum Pathol. 2014;45(3):533–539.
   PubMed Web of Science ®Google Scholar
• Lv X, Ye G, Zhang X, et al. p16 Methylation was associated with the development, age, hepatic viruses infection of hepatocellular carcinoma, and p16 expression had a poor survival: a systematic meta-analysis (PRISMA). Medicine (Baltimore). 2017;96(38):e8106.
   PubMed Web of Science ®Google Scholar
• Gupta A, Ahmad MK, Mahndi AA, et al. Promoter methylation and relative mRNA expression of the p16 gene in cervical cancer in North Indians. Asian Pac J Cancer Prev. 2016;17(8):4149–4154.
   PubMedGoogle Scholar
• Haroun RA, Zakhary NI, Mohamed MR, et al. Assessment of the prognostic value of methylation status and expression levels of FHIT, GSTP1 and p16 in non-small cell lung cancer in Egyptian patients. Asian Pac J Cancer Prev. 2014;15(10):4281–4287.
   PubMed Web of Science ®Google Scholar
• Zhou C, Shen Z, Ye D, et al. The association and clinical significance of CDKN2A promoter methylation in head and neck squamous cell carcinoma: a meta-analysis. Cell Physiol Biochem. 2018;50(3):868–882.
   PubMedGoogle Scholar
• Kitamura H, Takemura H, Minamoto T. Tumor p16INK4 gene expression and prognosis in colorectal cancer. Oncol Rep. 2019;41(2):1367–1376.
   PubMed Web of Science ®Google Scholar